The United States has lost its measles elimination status, the designation it has held since 2000. The decision came from an independent regional commission that met in Washington from 10 to 13 November, and CDC confirmed it in a joint statement with partners on 17 November.

The commission’s finding was narrow and specific. According to the letter the Pan American Health Organization sent to the U.S. Secretary for Health on 13 November, one measles chain of transmission that began on 20 January 2025 persisted for more than twelve months inside the country. That duration was treated as sufficient evidence that the United States had re-established endemic measles transmission, which is what the loss of status means. The status for rubella and congenital rubella syndrome is unchanged.

What the review actually examined

PAHO’s Regional Monitoring and Re-Verification Commission, made up of outside experts, meets annually to review whether countries in the Americas are still free of endemic measles and rubella. For this meeting it went through the U.S. report, met the country’s own sustainability commission and spoke with national health authorities before reaching its conclusion.

The history matters for scale. PAHO member states committed to eliminating endemic measles in 1994, and in 2016 an international expert commission verified that every country in the region was free of the disease. That verification has been fragile ever since: Venezuela re-established endemic transmission in 2018, Brazil in 2019 and Canada in 2025. Venezuela regained its status in 2023 and Brazil in 2024. Countries that lose status are required to submit a corrective action plan setting out how they intend to get it back.

Twelve months is a surveillance threshold, not a change in the virus

It is worth being precise about what has and has not changed. Elimination is a verification category: a country keeps it while transmission stays interrupted, and loses it when a chain runs long enough to count as continuous. Nothing about the measles virus itself changed on 17 November, and nothing in either document suggests the risk to an individual who is already immune has moved.

The agency’s own framing was blunt about this. “The measles elimination designation is not what protects Americans. Vaccination does,” CDC Director Dr. Erica Schwartz said in the joint statement. She said the agency had invested $100 million in state and local health departments to reach affected communities, and added that losing a designation “doesn’t mean we abandon an evidence-based approach.”

What does change is administrative and epidemiological: the country is now classified as endemic for measles, its outbreak response and surveillance are subject to external re-verification, and a corrective plan is owed to the region.

The year behind the decision

CDC’s case page, updated on 12 November, counted 5,412 confirmed measles cases in the United States during 2026. Eighteen of those were in international visitors. The agency recorded 43 new outbreaks, defined as three or more related cases, and 96% of all confirmed cases were outbreak-associated — 3,831 from outbreaks that started this year and 1,385 from outbreaks that began in 2025.

For comparison, the same page reports 2,289 confirmed cases for the whole of 2025 and 285 for 2024. The shape of the 2026 outbreak year is also visible in the age bands: 951 cases (18%) were in children under 5, 2,183 (40%) were in people aged 5 to 19, and 2,240 (41%) were in adults 20 and older.

Severity tracked age in the way clinicians expect. Eleven per cent of cases were hospitalised — 591 people — but the rate was 17% among children under 5 and 15% among adults 20 and over, against 4% in the 5-to-19 group. CDC’s data also show how much of the outbreak sits among the unprotected: 96% of cases were in people who were unvaccinated or whose vaccination status was unknown, with 2% having one documented MMR dose and 2% two doses.

The coverage number that moved first

Measles is among the most transmissible infections known. CDC’s background page puts it plainly: if one person has measles, up to 9 out of 10 people in close contact will become infected if they are not protected. Community protection depends on coverage staying above roughly 95%.

That is the number that slipped. CDC reports that MMR coverage among U.S. kindergartners fell from 95.2% in the 2019–2020 school year to 92.4% in 2025–2026, leaving an estimated 280,000 kindergartners at risk that year. National averages also hide local pockets where coverage is lower still, which is where outbreaks tend to start.

What this means for an individual decision

For a reader, the practical content of the news is the vaccination schedule, which has not changed. CDC recommends two MMR doses for children, at 12 to 15 months and again at 4 to 6 years. Adults are recommended to have at least one documented dose, and adults at higher risk are recommended to have two if they have no other evidence of immunity, spaced at least 28 days apart. Acceptable evidence of immunity includes written documentation of vaccination, laboratory evidence of immunity, or laboratory confirmation of past measles infection.

Two doses are about 97% effective at preventing measles and one dose about 93%. Anyone travelling internationally should be fully vaccinated at least two weeks before departure; if the trip is sooner than that, CDC still advises getting a dose. Infants aged 6 to 11 months travelling abroad should get one dose early and then two more after their first birthday, and CDC does not recommend measles vaccine for infants younger than 6 months. During an outbreak, public health authorities may recommend an extra dose for people who have only one documented dose.

For people exposed without immunity, the agency notes that MMR within 72 hours of first exposure may provide some protection or a milder illness, and that high-risk patients may be offered immune globulin within six days. Those are clinical decisions, not household ones — the details of how vaccines are given, and what can go wrong at the injection site, are covered in our report on vaccine shoulder injuries.

The vitamin A question

Measles coverage online reliably produces a vitamin A recommendation, and here the guidance is real but narrower than the version that circulates. WHO recommends two doses of vitamin A for all suspected measles cases in children under 5, given immediately on diagnosis and repeated the next day, with a third dose four to six weeks later for children showing clinical signs of vitamin A deficiency with eye complications. The agency’s stated rationale is that this restores the low vitamin A levels seen even in well-nourished children and can help prevent complications including eye damage, and that supplements may reduce the number of measles deaths.

That is a treatment protocol for a diagnosed case in a young child, delivered under clinical direction. It is not a preventive, it is not aimed at adults, and it does not substitute for vaccination.

The wider picture

The loss of status is a national verdict inside a global trend. WHO estimates 95,000 measles deaths in 2024, mostly among unvaccinated or under-vaccinated children under 5, and says vaccination averted an estimated 59 million deaths between 2000 and 2024. Coverage is moving the wrong way: 84% of children received a first dose in 2025, slightly below the 2019 level of 86%, and 77% received both doses. WHO and UNICEF estimate about 29 million infants were left under-protected in 2025. The agency’s Strategic Advisory Group of Experts has concluded that measles elimination is under threat as the disease resurges in countries that had achieved it or come close.

What we did not find

Neither document claims the designation change alters transmission on its own, and neither offers a timeline for regaining it. PAHO’s letter says only that the United States is expected to submit a corrective plan and that the organisation is ready to support the process.

Mortality figures for 2026 are also less settled than case counts. CDC notes on its data page that it is working with the Council of State and Territorial Epidemiologists to develop a standardised case definition for measles deaths, work intended to make classification consistent across jurisdictions — a sign that the death tally is still being reviewed rather than final.

For anyone unsure of their own vaccination record, the practical step is a records check and a conversation with a healthcare professional, who can say whether a dose is indicated. This article reports what the agencies published; it is not medical advice, and our medical disclaimer explains the difference.